earnings

Medtronic’s Q2 results top estimates despite profit slide
Medtronic’s Q2 results top estimates despite profit slide
Mass Device
Medtronic
earnings
devices
Flag link:
Momenta Moves On
Momenta Moves On
Motley Fool
Momenta
earnings
biosimilars
M281
M254
Flag link:
Flat quarter for Bayer, shares drop 3%
Flat quarter for Bayer, shares drop 3%
GoinPharma
Bayer
earnings
Flag link:
ImmunoGen Waits to Leap "Forward"
ImmunoGen Waits to Leap "Forward"
Motley Fool
Immunogen
earnings
Flag link:
Waiting for bluebird bio to Sing at ASH
Waiting for bluebird bio to Sing at ASH
Motley Fool
Bluebird Bio
earnings
ASH
CAR-T
Flag link:
Dentsply announces workforce reductions & restructuring plan, posts Q3 miss
Dentsply announces workforce reductions & restructuring plan, posts Q3 miss
Mass Device
Dentsply Sirona
layoffs
dental health
earnings
Flag link:
AstraZeneca Reports First Quarter of Sustainable Product Sales Growth Since 2014
AstraZeneca Reports First Quarter of Sustainable Product Sales Growth Since 2014
BioSpace
AstraZeneca
earnings
Flag link:
Here's Why Myriad Genetics Dropped as Much as 10.8% Today
Here's Why Myriad Genetics Dropped as Much as 10.8% Today
Motley Fool
Myriad Genetics
earnings
Flag link:
Despite Trulicity success, Lilly can't escape diabetes concerns
Despite Trulicity success, Lilly can't escape diabetes concerns
Biopharma Dive
Eli Lilly
diabetes
earnings
Trulicity
Flag link:
Mylan N.V. Improves in the Third Quarter Thanks to International Sales
Mylan N.V. Improves in the Third Quarter Thanks to International Sales
Motley Fool
Mylan
earnings
Flag link:
Exelixis Grabs Its Share of the Kidney-Cancer Treatment Market
Exelixis Grabs Its Share of the Kidney-Cancer Treatment Market
Motley Fool
Exelixis
earnings
kidney cancer
Cabometyx
Flag link:
Becton Dickinson’s Q4 meets earnings expectations, beats on revenue
Becton Dickinson’s Q4 meets earnings expectations, beats on revenue
Mass Device
earnings
Becton Dickinson
devices
Flag link:
Excellent quarter from AbbVie, but market still skeptic about pipeline
Excellent quarter from AbbVie, but market still skeptic about pipeline
GoinPharma
AbbVie
earnings
Imbruvica
Flag link:
Early November Brings More Quarterly Reports
Early November Brings More Quarterly Reports
BioSpace
earnings
Akcea
Mylan
Eli Lilly
Regeneron
Flag link:
Excellent quarter for GlaxoSmithKline
Excellent quarter for GlaxoSmithKline
GoinPharma
GSK
earnings
Flag link:
Positive quarter from Takeda, waiting for completion of Shire deal
Positive quarter from Takeda, waiting for completion of Shire deal
GoinPharma
Takeda
Shire
M&A
earnings
Flag link:
Excellent quarter from Teva, shares soar
Excellent quarter from Teva, shares soar
GoinPharma
Teva Pharmaceutical
earnings
Flag link:
AbbVie lifts profit target after cancer drug powers quarterly beat
AbbVie lifts profit target after cancer drug powers quarterly beat
Yahoo/Reuters
AbbVie
earnings
Flag link:
Amgen reckons with biosimilar and pricing pressures
Amgen reckons with biosimilar and pricing pressures
Biopharma Dive
Amgen
earnings
biosimilars
Aimovig
Flag link:
Aging Blockbusters Send Amgen Inc.'s Bottom Line Lower
Aging Blockbusters Send Amgen Inc.'s Bottom Line Lower
Motley Fool
Amgen
earnings
Flag link:

Pages